September 1, 2014

Pfizer and Protalix BioTherapeutics last week announced that the Food and Drug Administration approved Elelyso (taliglucerase alfa) for injection for pediatric patients.

September 1, 2014

Pfizer last week announced that the Food and Drug Administration has granted fast track designation to the company’s investigational Clostridium difficile (C. difficile) vaccine candidate (PF-06425090). 

August 28, 2014

Rx Safes, manufacturer of fingerprint recognition home prescription lockboxes, on Thursday announced that it is waging a new war on drugs to reduce prescription drug abuse, backed by a national media campaign.

August 28, 2014

The steep decline in the use of hormone therapy has spawned a prevalent but preventable side effect: Millions of women suffering in silence with hot flashes, according to a study by a Yale School of Medicine researcher and colleagues.

August 28, 2014

Walgreens on Wednesday announced a tetanus, diphtheria, pertussis (Tdap) vaccination voucher program, in collaboration with the Alaska Department of Health and Social Services, to help protect against pertussis (whooping cough). 

August 27, 2014

GlaxoSmithKline announced that the Food and Drug Administration approved its supplemental new drug application for Promacta (eltrombopag), a once-daily medication for patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy.

August 27, 2014

The International Society for Pharmaceutical Engineering on Wednesday announced that it has released a preview of its Drug Shortages Prevention Plan aimed at helping the pharmaceutical industry avoid drug shortages and maintain a reliable supply of medications. 

August 27, 2014

Canada's Premiers gathered in Charlottetown for the latest Council of the Federation meeting starting on Aug. 26, and health reform is a key topic. The pharmacy community is urging provinces to consider further expanding pharmacists' role as they can make important contributions to improving patient outcomes, reducing costs and ensuring the sustainability of the health care system.

August 26, 2014

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co. announced that Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States.

August 26, 2014

A new report is shining a light on a key role pharmacists can play in helping patients understand the medicine they’re taking.

 

August 25, 2014

Pharmaceutical company Iroko announced today that a new version its anti-inflammatory drug Zorvolex had been approved by the Food and Drug Administration.

August 25, 2014

ViiV Healthcare announced that the Food and Drug Administration has approved Triumeq (abacavir 600 mg, dolutegravir 50 mg and lamivudine 300 mg) tablets for the treatment of HIV-1 infection.

August 25, 2014

With the National Association of Chain Drug Stores Total Store Expo currently underway in Boston, the Boston Globe published an op-ed in its opinion section, Podium, which was co-authored by Steven Anderson, president and CEO of NACDS and Michael Malloy, PharmD and dean of the MCPHS University School of Pharmacy - Worcester/Manchester.

August 25, 2014

Biotech company Roche will be acquiring research and pharmaceutical company InterMune for $8.3 billion, it announced over the weekend. 

August 22, 2014

The Drug Enforcement Administration issued a final rule rescheduling hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act.

August 21, 2014

Brandperx in November will be launching its Patientperx platform, a diseases-state specific health resource that's being published in partnership with Reader's Digest. 

August 21, 2014

GlaxoSmithKline announced FDA approval for Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid medicine for the treatment of asthma in patients 12 years of age and older.

August 20, 2014

Researchers at the University of California, San Diego School of Medicine concluded that aspirin, in addition to preventing pain and inflammation, actually helps hasten the end of inflammation in a study published this week in the online early edition of PNAS.

August 19, 2014

PharmaJet, the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL, the maker of Afluria (influenza vaccine) on Tuesday announced the Food and Drug Administration has approved the PharmaJet Stratis 0.5mL Needle-Free Jet Injector for delivery of Afluria in individuals ages 18 years to 64 years.

August 19, 2014

Walgreens on Tuesday announced that flu shots are now available at all locations, including pharmacies and Healthcare Clinics.

 

August 19, 2014

The Food and Drug Administration has granted tentative approval for Basaglar (insulin glargine injection), which is used to improve glycemic control in adults with Type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with Type 1 diabetes.

August 19, 2014

Nearly half of women age 45 years or older who experience symptoms of overactive bladder report their current treatment does not address their OAB symptoms, according to a recent survey conducted by The Harris Poll on behalf of Allergan.

August 14, 2014

The Food and Drug Administration has announced approval for Belsomra (suvorexant) tablets, which are used to treat insomnia.

August 14, 2014

Pragma Pharmaceuticals announced the relaunch of Moxatag (amoxicillin extended-release tablets), 775 mg.